Literature DB >> 31269490

Robotic-Assisted versus Laparoscopic Distal Pancreatectomy: The Results of a Case-Matched Analysis from a Tertiary Care Center.

Marco Vito Marino1,2, Antonello Mirabella3, Marcos Gomez Ruiz4, Andrzej Lech Komorowski5.   

Abstract

BACKGROUND: Laparoscopic distal pancreatectomy (LDP) has been adopted relatively slowly despite the benefits of minimally invasive approach. The robotic approach can overcome the limitations of LDP, thus increasing the acceptance of minimally invasive distal pancreatectomy.
METHODS: We performed a 1:1 retrospective case-matched comparison among 2 groups of 35 patients who underwent robotic-assisted distal pancreatectomy (RDP) or LDP from August 2014 to April 2017.
RESULTS: The operative time was similar in both groups (230 RDP vs. 205 LDP min, p = 0.382). The robotic group had a lower estimated blood loss (95 vs. 275 mL, p = 0.035). The spleen preservation rate was higher in the RDP group (100 vs. 66.7%, p = 0.027), while the conversion rate to open surgery was higher in the laparoscopic group (14.3 vs. 2.9%, p = 0.048). The overall complication rate was lower in the robotic group (25.7 vs. 37.1%, p = 0.044). There was no statistically significant difference in oncologic outcomes between the groups in terms of R0 resection rate (100% RDP vs. 85% LDP, p = 0.233) and number of harvested lymph nodes (14.4 RDP vs. 10.8 LDP, p = 0.678).
CONCLUSIONS: The RDP showed a lower estimated blood loss, conversion, and morbidity rate. It offered a higher spleen preservation rate in comparison to LDP while maintaining comparable oncologic outcomes.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Computer-assisted surgery; Laparoscopic surgery; Morbidity; Outcomes assessment; Pancreatic resection

Mesh:

Year:  2019        PMID: 31269490     DOI: 10.1159/000501428

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  7 in total

1.  "Kimura-first" strategy for robotic spleen-preserving distal pancreatectomy: experiences from 61 consecutive cases in a single institution.

Authors:  Xianchao Lin; Ronggui Lin; Fengchun Lu; Yuanyuan Yang; Congfei Wang; Haizong Fang; Heguang Huang
Journal:  Gland Surg       Date:  2021-01

2.  Minimally invasive (laparoscopic and robot-assisted) versus open approach for central pancreatectomies: a single-center experience.

Authors:  Frederick Huynh; Charles Jimenez Cruz; Ho Kyoung Hwang; Woo Jung Lee; Chang Moo Kang
Journal:  Surg Endosc       Date:  2021-03-04       Impact factor: 4.584

3.  Minimally invasive distal pancreatectomy: Laparoscopic versus robotic approach-A cohort study.

Authors:  Hon-Fan Lai; Yi-Ming Shyr; Bor-Shiuan Shyr; Shih-Chin Chen; Shin-E Wang; Bor-Uei Shyr
Journal:  Health Sci Rep       Date:  2022-07-04

4.  Is robotic distal pancreatectomy better than laparoscopic distal pancreatectomy after the learning curve? A systematic review and meta-analysis.

Authors:  Chuwen Chen; Jing Hu; Hao Yang; Xuejun Zhuo; Qiuping Ren; Qingbo Feng; Miye Wang
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

5.  Rate of Post-Operative Pancreatic Fistula after Robotic-Assisted Pancreaticoduodenectomy with Pancreato-Jejunostomy versus Pancreato-Gastrostomy: A Retrospective Case Matched Comparative Study.

Authors:  Marco V Marino; Adrian Kah Heng Chiow; Antonello Mirabella; Gianpaolo Vaccarella; Andrzej L Komorowski
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

6.  Short- and long-term outcomes after minimally invasive versus open spleen-saving distal pancreatectomies.

Authors:  Madeline Chee; Chuan-Yaw Lee; Ser-Yee Lee; London L P J Ooi; Alexander Y F Chung; Chung-Yip Chan; Brian K P Goh
Journal:  J Minim Access Surg       Date:  2022 Jan-Mar       Impact factor: 1.407

7.  Comparison of 3 Minimally Invasive Methods Versus Open Distal Pancreatectomy: A Systematic Review and Network Meta-Analysis.

Authors:  Yunxiao Lyu; Yunxiao Cheng; Bin Wang; SiCong Zhao; Liang Chen
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2020-09-02       Impact factor: 1.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.